Awakening | 'Exploring Arrakis' Trailer

Arrakis’s DM1 drug program represents a rationally designed small molecule genetic medicine directed at a pathogenic RNA to achieve reversal of myotonia in an animal model of DM1. Utilizing the ...
Southwest Research Institute (SwRI) has received a three-year, $2,999,998 million grant from NASA to identify and ...